![]() ![]() Measuring blood telomeres may predict which patients are headed for cancer, many years before their actual diagnosis, according to a new study by scientists from Harvard University and Northwestern University, published in EBioMedicine. ![]() Telomere Changes: A New Biomarker to Predict Cancer It’s the only commercially available telomere test that reports the percentage of short telomeres, the most crucial information in telomere assessment. Telomere length has also been linked to life expectancy, with a new study of 64,637 people, published in Journal of the National Cancer Institute, reporting that over a 22-year period, participants with the shortest telomeres had a 40 percent higher death rate, compared to those with the longest.Īn advanced blood test, Telomere Analysis Technology ™ (TAT ™) - offers insights into how fast patients’ bodies are aging at the cellular level. Telomeres shorten as a cell ages, with such factors as oxidative stress and chronic inflammation speeding up the process. These findings build on Nobel Prize-winning science: the discovery of how telomeres and the enzyme telomerase protect chromosomes from degrading during cell division. What’s more, telomere testing may identify patients at risk for certain diseases years before diagnosis, independent of other known factors, new research suggests. The length of telomeres - protective caps at the end of chromosomes often compared to plastic tips on shoelaces - could be an important predictor of increased danger for a range of disorders, from cancer to cardiovascular disease and type 2 diabetes. ![]() Telomere Testing May Predict Health Risks Years in Advance ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |